Medx Health Corp
XTSX:MDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medx Health Corp
XTSX:MDX
|
CA |
|
N
|
Nordex SE
DUS:NDX1
|
DE |
|
N
|
Noble Metal Group Inc
XTSX:NMG.H
|
CA |
|
Lotus Resources Ltd
OTC:LTSRD
|
AU |
|
U
|
United Utilities Group PLC
F:UUEC
|
UK |
|
R
|
Rotshtein Realestate Ltd
TASE:ROTS
|
IL |
Balance Sheet
Balance Sheet Decomposition
Medx Health Corp
Medx Health Corp
Balance Sheet
Medx Health Corp
| Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
2
+40%
|
1
-40%
|
1
-16%
|
1
+15%
|
0
-73%
|
0
+17%
|
1
+81%
|
0
-37%
|
1
+25%
|
0
-21%
|
1
+37%
|
1
+22%
|
1
-16%
|
1
-3%
|
0
-33%
|
1
+68%
|
1
0%
|
1
-2%
|
1
-4%
|
1
+28%
|
|
| Liabilities | ||||||||||||||||||||||
| Accounts Payable |
1
|
2
|
2
|
2
|
1
|
1
|
1
|
0
|
2
|
1
|
3
|
0
|
2
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
2
|
3
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
1
|
2
|
|
| Short-Term Debt |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
4
|
|
| Current Portion of Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
2
|
|
| Other Current Liabilities |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
3
|
3
|
4
|
5
|
2
|
4
|
4
|
5
|
5
|
4
|
3
|
2
|
2
|
2
|
2
|
3
|
3
|
2
|
7
|
7
|
8
|
|
| Long-Term Debt |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
1
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
3
N/A
|
4
+25%
|
4
+11%
|
6
+41%
|
2
-57%
|
4
+60%
|
4
+10%
|
5
+26%
|
5
-6%
|
4
-19%
|
3
-32%
|
3
+11%
|
3
-14%
|
2
-17%
|
2
+1%
|
3
+50%
|
3
-15%
|
4
+56%
|
8
+79%
|
8
+0%
|
9
+20%
|
|
| Equity | ||||||||||||||||||||||
| Common Stock |
5
|
7
|
7
|
7
|
11
|
11
|
12
|
12
|
13
|
15
|
15
|
16
|
17
|
19
|
22
|
20
|
23
|
24
|
24
|
27
|
27
|
|
| Retained Earnings |
6
|
8
|
10
|
12
|
15
|
17
|
18
|
19
|
20
|
22
|
22
|
22
|
24
|
25
|
29
|
31
|
34
|
40
|
45
|
49
|
53
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
1
|
2
|
2
|
2
|
2
|
3
|
3
|
4
|
4
|
4
|
5
|
6
|
7
|
8
|
10
|
11
|
12
|
14
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
3
|
2
|
|
| Total Equity |
1
N/A
|
1
-3%
|
3
-110%
|
4
-73%
|
1
+77%
|
3
-238%
|
4
-10%
|
5
-20%
|
4
+1%
|
3
+24%
|
2
+34%
|
2
-6%
|
2
+24%
|
2
+18%
|
2
-3%
|
3
-86%
|
2
+28%
|
4
-75%
|
7
-95%
|
7
-1%
|
9
-19%
|
|
| Total Liabilities & Equity |
2
N/A
|
2
+40%
|
1
-40%
|
1
-16%
|
1
+15%
|
0
-73%
|
0
+17%
|
1
+81%
|
0
-37%
|
1
+25%
|
0
-21%
|
1
+37%
|
1
+22%
|
1
-16%
|
1
-3%
|
0
-33%
|
1
+68%
|
1
0%
|
1
-2%
|
1
-4%
|
1
+28%
|
|
| Shares Outstanding | ||||||||||||||||||||||
| Common Shares Outstanding |
15
|
15
|
15
|
15
|
27
|
27
|
34
|
35
|
40
|
60
|
71
|
74
|
98
|
113
|
135
|
144
|
176
|
184
|
184
|
262
|
272
|
|